DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on epigenetic regulation to develop treatments for acute organ injury.